Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insured
By Tami Luhby, CNN Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly…
Continue Reading